SCHEMBL24587232

SCHEMBL24587232

OC[C@H](OCc1ccccc1)[C@@H](OCc1ccccc1)[C@H](OCc1ccccc1)[C@@H](CO)OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.43
SLC1A2 P43004 2/20 0.43
SLC1A1 P43005 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
MEN1 O00255 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
KMT2A Q03164 1/20 0.43
TSHR P16473 3/20 0.43
MAPT P10636 1/20 0.43
ALDH1A1 P00352 2/20 0.42
IDO1 P14902 1/20 0.40
AGXT P21549 1/20 0.39
SLC6A2 P23975 2/20 0.38
SLC6A3 Q01959 2/20 0.38
LMNA P02545 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18286530 1.00 SLC1A3 (0.43) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19
SCHEMBL9439481 1.00 SLC1A3 (0.43) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19
SCHEMBL15879320 1.00 SLC1A3 (0.43) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19
SCHEMBL14747382 0.96 SLC1A3 (0.43) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19
SCHEMBL31357360 0.96 SLC1A3 (0.43) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19
SCHEMBL32662980 0.96 SLC1A3 (0.43) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19
SCHEMBL18591521 0.91 MAPT (0.41) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19
SCHEMBL15892780 0.91 MAPT (0.41) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19
SCHEMBL19928544 0.91 MAPT (0.38) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19
SCHEMBL15366358 0.90 TSHR (0.48) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240065261-A1 PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME UNIV NEW YORK STATE RES FOUND (US) 2024-02-29 US disclosed
US-20240065261-A1 PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME UNIV NEW YORK STATE RES FOUND (US) 2024-02-29 US disclosed
WO-2022140458-A1 PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240065261-A1 PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME SLC29A1, SLC29A2, SLC43A1 SLC1A3 128/4885SLC1A2 150/4885SLC1A1 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.